Successful dabrafenib transition after vemurafenib-induced toxic epidermal necrolysis in a patient with metastatic melanoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAAD Case Reports 2018-10, Vol.4 (9), p.930-933
Hauptverfasser:	Tahseen, Ahmed I., Patel, Neel B.
Format:	Artikel
Sprache:	eng
Schlagworte:	allergic reaction antitumor response antitumor response toxic epidermal necrolysis BRAF inhibitor BRAF inhibitor Stevens-Johnson syndrome BRAF inhibitor toxic epidermal necrolysis Case Report coBRIM adverse effect coBRIM allergic reaction coBRIM hypersensitivity cross-reactivity dabrafenib dabrafenib toxic epidermal necrolysis dabrafenib vemurafenib dabrafenib vemurafenib switch hypersensitivity lymphocyte transformation test Stevens-Johnson syndrome lymphocyte transformation test toxic epidermal necrolysis melanoma metastatic melanoma Stevens-Johnson syndrome Stevens-Johnson syndrome desensitization sulfonamide sulfonamide cross-reactivity sulfonamide drug sulfonamide toxic epidermal necrolysis toxic epidermal necrolysis toxic epidermal necrolysis desensitization toxic epidermal necrolysis/Stevens-Johnson syndrome vemurafenib vemurafenib adverse effect vemurafenib allergic reaction vemurafenib dabrafenib cross-reactivity vemurafenib hypersensitivity vemurafenib toxic epidermal necrolysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!